Actively Recruiting
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
Led by Huazhong University of Science and Technology · Updated on 2021-02-10
10000
Participants Needed
1
Research Sites
548 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV with the hematological malignancies, and second goal is to investigate the genetic mechanisms of immune escape and tumorigenesis of chronic EBV infection.
CONDITIONS
Official Title
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Immunocompetent subjects with high Epstein-Barr virus DNA load (>1×10^3 copies/ml) detected in blood during physical examination
- Willing to be followed up by telephone or face-to-face interview
You will not qualify if you...
- Subjects with diagnosed immunodeficiency
- Subjects who have taken or plan to take immunosuppressive drugs
- Subjects diagnosed with a blood disorder
- Subjects diagnosed with precancerous lesions or malignant tumors with life expectancy less than one year
- Psychological illness preventing understanding or voluntary participation
- Pregnant women
- No written informed consent provided
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji hospital, Tongji medical collage of HUST
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
J
Jin Huang, PhD.and MD.
CONTACT
J
Jianfeng Zhou, PhD.and MD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here